Debiotech announced today that it's partner JMS received Shonin approval from the Kosheirodosho (MHW) for its IV Exprés pump and giving sets, to be marketed by JMS in Japan under the tradename of "I-Fusor". "We are very pleased with this approval, as it will enable the marketing of the IV Exprés product line in Japan", says Ary Saaman, Director of Regulatory Affairs for Debiotech.

Debiotech already obtained clearance in the US from the Food and Drug Administration (FDA) for its IV Expres infusion pump.

The IV Exprés is Debiotech's micropump for hospital and homecare use. It combines ease of use with a variety of infusion modes and advanced features, e.g. remote communication. Last year, Debiotech licensed the pump to JMS for the Japanese market.